Medications

GLP-1 Medications are too powerful to prescribe over chat

GLP-1 Medications are
too powerful to prescribe
over chat

GLP-1 medications require expert guidance. Unsupervised GLP-1 use has been shown to cause substantial muscle loss and worse rebound weight gain after use. Both can lead to future health issues. We support you physically and mentally — so you can shed weight safely while adapting and thriving through your transformation.

Get Started Today
20%

Average amount of weight lost using GLP-1 medications is 18-22%, depending on the specific drug

90%

Reduction of common side effects experienced by our patients due to our precision dosing, which also reduces serious side effects by 10%

38%

Amount of weight lost in lean body mass due to GLP-1 drugs

How GLP-1 Medications work

Based on your unique biology and needs, your Aayu Well physician will decide which drug will be best for you. The drugs in this class include Ozempic®, Wegovy®, Zepbound®, and Mounjaro®. All are administered by injection.

Fatty Tissue
  • Increases fat burning
  • Improves glucose uptake
Liver
  • Decreases glucose production and output to blood
  • reduces fat storage in the liver cells
Stomach
  • Slows down the emptying of the stomach by reducing montility
  • Reduces acid secretion
Pancreas
  • Improves hormonal secretions and leads to improved blood glucose levels. [Improved insulin secretion, reduces glucagon secretion]
  • Grows insulin-producing cells in the pancreas. [Beta cells]
Brain
  • Appetite regulation
  • Reduction in substance seeking behaviors
  • Potential impact on cognitive functions
Heart & Blood Vessels
  • Better glucose utilization
  • Dilates blood vessels and increases cardiac output
  • Reduced fatty acid metabolis
Immune System
  • Reduces inflammation
  • Improves gut heath
  • Reduces risk of heart disease in high risk patients
Skeletal Muscle
  • Increases glucose utilization
  • Improves blood flow
BEYOND WEIGHT LOSS

The many
benefits of GLP-1 Medications

Glucagon Like Peptides-1 (GLP-1) Agonist medications, originally developed for Type 2 diabetes, have shown to have a number of other potential benefits, particularly in managing obesity.

Reduces the risk of metabolic diseases
  • Lowers blood pressure
  • Improves fatty liver disease and liver inflammation
Reduces insulin resistance and improves blood glucose levels
  • Obesity can lead to heart diseases like high blood pressure and heart attacks, as excess fat strains the heart and clogs blood vessels.
Reduces inflammation in various organs
  • Guts: Reduces the pro-inflammatory cytokines in the guts.
  • Heart: Reduces vascular inflammation and oxidative stress by improving endothelial function
  • Brain: Improves inflammatory markers in brain and could improve the risk of Alzheimer’s*
Improves digestive function
  • Reduces overeating
  • Improves alcohol consumption-related behaviors
Reduces risk of arthritis
  • Weight loss reduces wear and tear on weight bearing joints
  • Can improve joint aches and pains
Improves sleep apnea
  • Weight loss significantly improves obstructive sleep apnea
  • Improves energy levels

Available GLP-1 Medications In The U.S.

Glucagon-Like Peptide-1 (GLP-1) agonist medications are approved for the treatment of Obesity and Type 2 Diabetes Mellitus under various brand names.

Saxenda (Liraglutide)

Ozempic® (semaglutide) is a medication primarily used for managing type 2 diabetes in adults and for lowering the risk of major cardiovascular events, such as stroke, heart attack, or death in adults with type 2 diabetes who have heart disease. It's not currently FDA-approved for weight loss, but clinical trials have shown effectiveness in this area as well.

Wegovy (Semaglutide)

Ozempic® (semaglutide) is a medication primarily used for managing type 2 diabetes in adults and for lowering the risk of major cardiovascular events, such as stroke, heart attack, or death in adults with type 2 diabetes who have heart disease. It's not currently FDA-approved for weight loss, but clinical trials have shown effectiveness in this area as well.

Mounjaro (Tirzepatide)

Ozempic® (semaglutide) is a medication primarily used for managing type 2 diabetes in adults and for lowering the risk of major cardiovascular events, such as stroke, heart attack, or death in adults with type 2 diabetes who have heart disease. It's not currently FDA-approved for weight loss, but clinical trials have shown effectiveness in this area as well.

Rybelsus (Semaglutide)

Ozempic® (semaglutide) is a medication primarily used for managing type 2 diabetes in adults and for lowering the risk of major cardiovascular events, such as stroke, heart attack, or death in adults with type 2 diabetes who have heart disease. It's not currently FDA-approved for weight loss, but clinical trials have shown effectiveness in this area as well.

Trulicity® (Dulaglutide)

Ozempic® (semaglutide) is a medication primarily used for managing type 2 diabetes in adults and for lowering the risk of major cardiovascular events, such as stroke, heart attack, or death in adults with type 2 diabetes who have heart disease. It's not currently FDA-approved for weight loss, but clinical trials have shown effectiveness in this area as well.

Saxenda (Liraglutide)

Ozempic® (semaglutide) is a medication primarily used for managing type 2 diabetes in adults and for lowering the risk of major cardiovascular events, such as stroke, heart attack, or death in adults with type 2 diabetes who have heart disease. It's not currently FDA-approved for weight loss, but clinical trials have shown effectiveness in this area as well.

Saxenda (Liraglutide)

Ozempic® (semaglutide) is a medication primarily used for managing type 2 diabetes in adults and for lowering the risk of major cardiovascular events, such as stroke, heart attack, or death in adults with type 2 diabetes who have heart disease. It's not currently FDA-approved for weight loss, but clinical trials have shown effectiveness in this area as well.

Side effects: Minimized

GLP-1 medications can have serious side effects, especially with unsupervised use, but with experienced use and precise dosing, Aayu Well’s focus on safety will minimize adverse reactions.

Get Started Today

Common side effects

Gastrointestinal discomfort (nausea, vomiting, diarrhea, abdominal pain, constipation), appetite changes, dizziness, and reactions at the injection site.

Serious concerns

Hypoglycemia (notably with other diabetes drugs), increased heart rate, hypotension, and anxiety.

Rare risks

Potential for thyroid cancer, pancreatitis, complications with diabetic retinopathy, allergic reactions, and kidney or liver issues.